Rifampin: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
** Weight <60 kg: 600 mg p.o. daily |
** Weight <60 kg: 600 mg p.o. daily |
||
** Weight >60 kg: 450 mg p.o. twice daily |
** Weight >60 kg: 450 mg p.o. twice daily |
||
| + | |||
| + | == Safety == |
||
| + | |||
| + | === Drug-Drug Interactions === |
||
| + | |||
| + | * Multiple |
||
| + | * Other antibiotics include [[clindamycin]], [[doxycycline]], [[linezolid]], [[moxifloxacin]], [[trimethoprim]], and [[fusidic acid]] |
||
[[Category:Rifamycins]] |
[[Category:Rifamycins]] |
||
Revision as of 22:12, 22 October 2022
- Inhibits bacterial DNA-dependent RNA polymerase
- Never given alone due to rapid resistance
- Adverse effects include drug-drug interactions, rash, hepatitis, influenza-like illness, neutropenia, and thrombocytopenia
- Avoid in liver failure
Dosing
- As adjunct to fluoroquinolone for Staphylococcus aureus:
- Weight <60 kg: 600 mg p.o. daily
- Weight >60 kg: 450 mg p.o. twice daily
Safety
Drug-Drug Interactions
- Multiple
- Other antibiotics include clindamycin, doxycycline, linezolid, moxifloxacin, trimethoprim, and fusidic acid
